Recognition of oligosaccharide molecular targets by...

Details Recognition of oligosaccharide molecular targets by... Recognition of oligosaccharide molecular targets by...

2007-03-30

2010-02-16

Tsang, Cecilia (Department: 1654)

Organic compounds -- part of the class 532-570 series

Organic compounds

Amino nitrogen containing

Reexamination Certificate

active

07662999

ABSTRACT:
Small molecule polycationic agents are used to modulate or interrupt biological processes by binding to oligosaccharide-based biomolecules. Compounds that inhibit nitric oxide, TNFα or other immunomodulators are provided and are useful for treating immunological disease and disease of an infectious disorder.

REFERENCES:
patent: 5998482 (1999-12-01), David et al.
patent: 6646149 (2003-11-01), Vermeulin et al.
patent: 6872852 (2005-03-01), Burns
patent: 6919483 (2005-07-01), Burns et al.
patent: 7160923 (2007-01-01), Vermeulin et al.
patent: 7208528 (2007-04-01), Vermeulin et al.
patent: 7388112 (2008-06-01), Burns et al.
patent: 7411002 (2008-08-01), Burns et al.
patent: 7432302 (2008-10-01), Burns et al.
Cirioni et al. “Single-Dose Intraperitoneal Magainins Improve Survival in a Gram-Negative-Pathogen Septic Shock Rat Model” Antimicrobial Agents and Chemotherapy, 2002, 46, 101-104.
Opal “The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis,” International Journal of Medical Microbiology, 2007, 297, 365-377.

Affiliated with

Also associated with

Rating

Recognition of oligosaccharide molecular targets by... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recognition of oligosaccharide molecular targets by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recognition of oligosaccharide molecular targets by... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4184982